News

health.wusf.usf.edu8d
Eli Lilly sues companies selling alternative versions of its weight loss drug
"FDA has never approved any form of tirzepatide for cosmetic weight loss," Lilly's complaint alleges, adding that ...
Investigating tirzepatide's role in weight loss and metabolic health
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
Medindia13d
Tirzepatide Supports Long-Term Weight Loss for Three Years
Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.
Eric Stonestreet Says Mounjaro Was a ‘Game Changer’ for Type 2 Diabetes, Weight Loss: ‘There’s a Pep in My Step' (Exclusive)
Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...
Healio1d
VIDEO: Tirzepatide’s approval for obstructive sleep apnea highlights need for screening
There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...
BioSpace8d
Lilly Takes Four Compounders to Court for Allegedly Producing Knockoff Tirzepatide
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Managed Healthcare Executive18h
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...
GlobalData on MSN8d
Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing
Eli Lilly has filed a lawsuit against four telehealth platforms selling compounded versions of its blockbuster metabolic ...